全文获取类型
收费全文 | 31318篇 |
免费 | 1927篇 |
国内免费 | 486篇 |
专业分类
耳鼻咽喉 | 142篇 |
儿科学 | 381篇 |
妇产科学 | 395篇 |
基础医学 | 1668篇 |
口腔科学 | 157篇 |
临床医学 | 2799篇 |
内科学 | 3320篇 |
皮肤病学 | 484篇 |
神经病学 | 1131篇 |
特种医学 | 451篇 |
外科学 | 1446篇 |
综合类 | 3720篇 |
预防医学 | 4150篇 |
眼科学 | 184篇 |
药学 | 10506篇 |
12篇 | |
中国医学 | 599篇 |
肿瘤学 | 2186篇 |
出版年
2024年 | 54篇 |
2023年 | 357篇 |
2022年 | 869篇 |
2021年 | 1038篇 |
2020年 | 874篇 |
2019年 | 841篇 |
2018年 | 855篇 |
2017年 | 831篇 |
2016年 | 877篇 |
2015年 | 1047篇 |
2014年 | 2323篇 |
2013年 | 2847篇 |
2012年 | 2252篇 |
2011年 | 2556篇 |
2010年 | 1872篇 |
2009年 | 1767篇 |
2008年 | 1760篇 |
2007年 | 1632篇 |
2006年 | 1382篇 |
2005年 | 1122篇 |
2004年 | 890篇 |
2003年 | 742篇 |
2002年 | 548篇 |
2001年 | 495篇 |
2000年 | 443篇 |
1999年 | 450篇 |
1998年 | 290篇 |
1997年 | 270篇 |
1996年 | 214篇 |
1995年 | 214篇 |
1994年 | 216篇 |
1993年 | 157篇 |
1992年 | 149篇 |
1991年 | 102篇 |
1990年 | 103篇 |
1989年 | 84篇 |
1988年 | 101篇 |
1987年 | 95篇 |
1986年 | 98篇 |
1985年 | 111篇 |
1984年 | 126篇 |
1983年 | 66篇 |
1982年 | 71篇 |
1981年 | 52篇 |
1980年 | 63篇 |
1979年 | 49篇 |
1978年 | 56篇 |
1977年 | 52篇 |
1976年 | 59篇 |
1975年 | 65篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
Summary: Oral administration of carbamazepine (CBZ)(15, 10, or 5 mg/kg) to mice significantly decreased both humoral and cellular immune responses evaluated by enumeration of direct and indirect plaque-forming spleen cells (PFC) and delayed–type hypersensitivity reaction (DTH) against sheep red blood cells (SRBC) as compared with those observed in normal control animals. Moreover, spleen T cells obtained from CBZ–treated donor mice were capable of decreasing both PFC and DTH responses of normal spleen cells transferred into lethally irradiated recipient animals. The immunodepressor effect of CBZ was observed even though administration of CBZ induced augmentation of spleen cellularity. 相似文献
102.
The pharmacology of synthetic
- and
-epibatidine, an alkaloid originally characterized from frog skin, were studied in different behavioral tests in mice and rats. The two enantiomers have potent antinociceptive activity in mice using the tail-flick test, with an ED50 of 6.1 and 6.6 μg/kg for
- and
-epibatidine respectively. Epibatidine enantiomers were 200 × more potent than
-nicotine as an antinociceptive agent in mice after s.c. administration. Their analgesic effect was blocked by mecamylamine but not naloxone, an opiate antagonist. Both
- and
-epibatidine have high affinity (Ki 54.7 and 55.0 pM, respectively) for [3H]nicotine binding site in rat brain. In addition, they reduced mice locomotor activity and body temperature in a dose-dependent manner. In rats trained with nicotine (0.4 mg/kg), epibatidine enantiomers engendered nicotine-like responding in a dose-related manner with an ED50 of 1.00 and 0.93 μg/kg for
and
, respectively. The discriminative effect of
- and
-epibatidine in rats was blocked by mecamylamine but not by hexamethonium. As in binding results, there was no significant enantioselectivity for these effects in our study. 相似文献
103.
本文对云南老山前、后方医院环境及战伤感染标本中绿脓杆菌(简称PA)进行调查,对所分离的333株PA进行血清学分型及药物敏感性测定。结果可看出除炸伤时创口易被泥土中PA污染外,前、后方医院环境也是感染源之一。提示各级医疗单位在战伤救治中对PA的监控十分重要。本文结果直接有益于前、后方医院对战创伤PA的防治。 相似文献
104.
Summary: Some of the properties of 4–bromobenzalde-hyde semicarbazone (compound IV), a prototype molecule of a new class of anticonvulsants, aryl semicarbazones, are described. Compound IV demonstrated activity in the maximal electroshock (MES) and subcutaneous pentylenetetrazol (scPTZ) tests in mice, with low neurotoxicity. When given orally to rats, it displayed high potency in the MES test and very low neurotoxicity, resulting in a high protective index (PI). Compound IV displayed no proconvulsant properties, and development of rapid tolerance was not noted. When administered intraperitoneally (i.p.) at doses of 100, 300, or 600 mg/kg to rats, compound IV had no effect on levels of γ-aminobu-tyric acid (GABA) or on GABA-T activity in whole brain. When tested in vitro, compound IV had no effect on rat brain GABA-T at a drug concentration of 100 μM. Although the activities of certain drug-metabolizing enzymes were increased after oral administration of compound IV to rats, these effects were less prominent than those of phenytoin (PHT) and carbamazepine (CBZ). The principal mode of action of compound IV does not appear to be an interaction with the GABAA receptor complex, and other mechanisms, involving excitatory amino acid neurotransmission, will have to be considered in future investigations of the anticonvulsant activity of this compound. 相似文献
105.
106.
S. Stegemann F. Leveiller D. Franchi H. de Jong H. Lindn 《European journal of pharmaceutical sciences》2007,31(5):249-261
Drug absorption, sufficient and reproducible bioavailability and/or pharmacokinetic profile in humans are recognized today as one of the major challenges in oral delivery of new drug substances. The issue arose especially when drug discovery and medicinal chemistry moved from wet chemistry to combinatorial chemistry and high throughput screening in the mid-1990s. Taking into account the drug product development times of 8–12 years, the apparent R&D productivity gap as determined by the number of products in late stage clinical development today, is the result of the drug discovery and formulation development in the late 1990s, which were the early and enthusiastic times of the combinatorial chemistry and high throughput screening. In parallel to implementation of these new technologies, tremendous knowledge has been accumulated on biological factors like transporters, metabolizing enzymes and efflux systems as well as on the physicochemical characteristics of the drug substances like crystal structures and salt formation impacting oral bioavailability. Research tools and technologies have been, are and will be developed to assess the impact of these factors on drug absorption for the new chemical entities.
The conference focused specifically on the impact of compounds with poor solubility on analytical evaluation, prediction of oral absorption, substance selection, material and formulation strategies and development. The existing tools and technologies, their potential utilization throughout the drug development process and the directions for further research to overcome existing gaps and influence these drug characteristics were discussed in detail. 相似文献
107.
本文测定了东乡族、回族吸毒者血清睾酮及促黄体生成素含量,发现血清睾酮含量吸毒组(n=40,X=340.14±101.49ng/dL)显著低于非吸毒组(n=42,X=444.50±98.83ng/dL),P<0.01。未观察到LH含量的改变。戒毒期20日以内组血清睾酮含量(n=16,X=297.93±78.22ng/dL),低于戒毒期20~60日组(n=17,X=386.29±89.45ng/dL),P<0.01。询问103名吸毒者,2月后性欲下降25人(24.27%),增强2人(1.94%),无变化13人(12.62%),不愿回答者63人(61.17%)。吸毒影响性功能,损害性健康。 相似文献
108.
对曾氏推导的药物蛋白结合率公式的修正娄建石(天津医科大学药理教研室,天津300070)测定药物蛋白结合率是药物代谢动力学研究中的重要内容之一。曾衍霖教授根据国外文献推导出药物蛋白结合率公式(1),为这方面的研究提供了很好的计算依据。本文作者在计算药物... 相似文献
109.
Richard A. Meisch 《Pharmacology, biochemistry, and behavior》1995,50(4):571-580
The establishment of orally delivered etonitazene (a potent opioid) as a reinforcer, was studied in eight rhesus monkeys. Initially, when given concurrent access to 2.5 μg/ml etonitazene and the water vehicle, five of the monkeys rejected the drug, whereas the other three monkeys consumed more drug solution than water. The five monkeys that rejected the drug solution underwent an acquisition phase to establish the drug as a reinforcer. A fading procedure was used to transfer control of responding from a 2% (wt/vol) ethanol solution to a 2.5 μg/ml etonitazene solution. Initially, responding was maintained by contingent deliveries of 2% ethanol. Next, across blocks of six or more sessions, increasing amounts of etonitazene were added in steps to the 2% ethanol solution. Subsequently, the 2% ethanol solution was decreased in steps to zero, leaving only the 2.5 μg/ml etonitazene present. When the fading procedure was completed, dose of etonitazene was varied by increasing the volume delivered, first under fixed ratio (FR 4) and then under an FR 8 reinforcement schedule. The same dose manipulations were made with the three monkeys who did not undergo the fading procedure because they preferred etonitazene over water when first tested. Etonitazene was established as a reinforcer for six of the eight monkeys because drug deliveries exceeded vehicle deliveries across a range of drug doses. 相似文献
110.
Jenny Weinstein BPhil BA Msc 《Health expectations》2006,9(2):98-109
OBJECTIVE: This study compares the process and outcomes of two approaches to engaging mental health (MH) service users in the quality assurance (QA) process. BACKGROUND: QA plays a significant role in health and care services, including those delivered in the voluntary sector. The importance of actively, rather than passively, involving service users in evaluation and service development has been increasingly recognized during the last decade. DESIGN: This retrospective small-scale study uses document analysis to compare two QA reviews of a MH Day Centre, one that took place in 1998 as a traditional inspection-type event and one that took place in 2000 as a collaborative process with a user-led QA agenda. Setting and participants The project was undertaken with staff, volunteers and service users in a voluntary sector MH Day Centre. Intervention The study compares the management, style, evaluation tools and service user responses for the two reviews; it considers staff perspectives and discusses the implications of a collaborative, user-led QA process for service development. RESULTS: The first traditional top-down inspection-type QA event had less ownership from service users and staff and served the main purpose of demonstrating that services met organizational standards. The second review, undertaken collaboratively with a user-led agenda focused on different priorities, evolving a new approach to seeking users' views and achieving a higher response rate. CONCLUSIONS: Because both users and staff had participated in most aspects of the second review they were more willing to work together and action plan to improve the service. It is suggested that the process contributed to an evolving ethos of more effective quality improvement and user involvement within the organization. 相似文献